logo
After Slashing Thousands of Jobs, Trump's FDA Wants to Use AI to Rapidly Approve New Drugs

After Slashing Thousands of Jobs, Trump's FDA Wants to Use AI to Rapidly Approve New Drugs

Gizmodoa day ago

AI is slowly permeating all corners of the federal government, including the Food and Drug Administration, where, according to a newly released paper, its top brass now wants to use automation to more 'efficiently' approve new drugs.
An article recently published in the Journal of the American Medical Association (JAMA) by Dr. Vinay Prasad, the FDA's director of a subagency that deals with vaccines, lays out a vision for revamping the agency that will supposedly 'increase efficiency' at the agency that regulates what you eat and drink. According to that article, a big way to make the agency more efficient is to use AI to do tasks that humans previously worked on. Specifically, it suggests using automation to speed up the drug approval process.
'The advent of generative artificial intelligence (AI) holds several promises to modernize the FDA and radically increase efficiency in the review process,' the paper reads, while noting that the agency has already implemented a pilot program that involves first 'AI-assisted scientific review.' The article also speaks of a need to 'reevaluate legacy processes at the agency that slow down decisions and do not increase safety.'
The study also claims it is looking to find ways to use technology to avoid 'animal cruelty' at the agency. It has supposedly done this by developing 'a road map to reduce animal testing using AI-based computational modeling to predict toxicity-leveraging chip technology.'
All of this news comes not long after the FDA purged thousands of staffers from its ranks, including those responsible for reviewing food safety. Now, in what has become a typical pivot for organizations looking to integrate AI, roles previously held by humans seem like they're being automated.
The article also suggests the use of 'big data' to help better assess how drug products are developed and reviewed. 'In the past, randomized clinical trials were the sole method used to determine if a product was safe and effective,' the article reads. 'Advances in causal inference in nonrandomized data, including the use of target trials, which attempt to balance confounding and time zero, have [the] potential to yield actionable causal conclusions, in many cases at lower cost.'
AI has been spread throughout other parts of the government, as the administration's supposed 'efficiency' mandate looks for newfangled methods to 'streamline' bureaucratic processes. If AI could technically help speed up some bureaucratic processes, a quick look at the way automation rollout is being handled at other agencies doesn't necessarily inspire confidence in the initiative, particularly when it comes to an agency tasked with overseeing drugs that go into Americans' bodies.
When it comes to new drugs, there are always guinea pigs involved in the process; now AI's impact will have to be factored into the effectiveness of the latest tests.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

At $120 off, the most comfortable noise-canceling headphones are now at a comfortable price
At $120 off, the most comfortable noise-canceling headphones are now at a comfortable price

Digital Trends

time20 minutes ago

  • Digital Trends

At $120 off, the most comfortable noise-canceling headphones are now at a comfortable price

One of the best things about wearing noise-canceling headphones is the great deal of comfort they bring when in loud, chaotic environments. However, they need to really fit around your head to get that seal, which can lead to some comfort issues. If you're the type that wants to float away into your music or studies, then the Sonos Ace are your absolute best bet, and they are the headphones we consider to be the overall best noise-canceling headphones for comfort. Unfortunately, they're usually $449, the same price as the brand new Sony WH-1000XM6. Now, however, in a deal you can find at any major retailer, they're discounted by $120, making them just $329. Tap the appropriate button below to make your purchase or keep reading to see just how comfortable the Sonos Ace are, and learn about the special link they have with the best soundbar Sonos makes. Why you should buy the Sonos Ace Looking through our guide to the best headphones with noise-canceling you might expect the Sonos Ace to be the lightest of them all, considering they're considered the most comfortable. At 11 ounces, however, they are not even close to the 8.8 ounces that multiple noise-cancellers are down to. It all comes down to excellent padding and what our Sonos Ace review will remind you is a delicate balance between clamping force and pressure. Your ears will stay cool, not stuffy, while wearing these headphones, too. And while our review says that the area where the Sonos Ace 'truly shine' is comfort and simplicity, it's also worth pointing out their one true special feature. (That they have a good transparency mode, tactile controls, and a 30 hour battery life shouldn't surprise you at this price.) They have a TV Audio Swap feature with select Sonos soundbars, such as the Sonos Arc or Sonos Arc Ultra. This feature takes the full-on Dolby Atmos surround sound and spatial audio of your soundbar and ports it to your headset — perfect for when you notice the spouse or little one nodding off on the couch. We're not sure how long the Sonos Ace are going to be $120 off, making them $329 instead of $449, but we're happy to see the deal while it lasts. This is a deal that just about every retailer is taking advantage of, so you should be able to take your pick based on your memberships, gift cards, or other reasons — just tap the appropriate button below to shop. If the deal is off, or the Sonos Ace aren't to your liking, check out these other fresh headphone deals for more great offers.

What RFK Jr.'s Changes to CDC Panel Mean for Vaccine Policy
What RFK Jr.'s Changes to CDC Panel Mean for Vaccine Policy

Bloomberg

time24 minutes ago

  • Bloomberg

What RFK Jr.'s Changes to CDC Panel Mean for Vaccine Policy

By , Rachel Cohrs Zhang, and Damian Garde Save Robert F. Kennedy Jr., secretary of health and human services, appointed eight new members of an expert panel that advises the federal government on immunization policy, including several vocal vaccine critics and one who identifies as an 'anti-vaxxer.' The appointments came days after Kennedy's dismissal on June 9 of all 17 members of the committee that advises the US government on vaccine safety and policy, saying that removing the entire panel was the only way to restore public confidence in immunizations.

Seattle's Allen Institute launches ‘moonshot' to create new approach to cell biology research
Seattle's Allen Institute launches ‘moonshot' to create new approach to cell biology research

Geek Wire

time24 minutes ago

  • Geek Wire

Seattle's Allen Institute launches ‘moonshot' to create new approach to cell biology research

A cross-section image of cells forming a hollow sphere, called a lumenoid. The colors mark different proteins expressed by the cells inside and outside of the sphere. (Allen Institute Image) Human cells, like the people they create, are dynamic and complex. And while researchers can create images and videos of how they move, organize and change their properties, it's hard to efficiently and accurately describe all that's happening. So a 75-person team at Seattle nonprofit Allen Institute is embarking on a 10-year project called CellScapes to devise a new language using mathematics to capture these essential processes. 'This is a new way of approaching very fundamental cell biology,' Ru Gunawardane, executive director and vice president of the Allen Institute for Cell Science, told GeekWire. 'We want to combine math and biophysical modeling, which are things that people are doing right now, but in a siloed way in very different systems.' Ru Gunawardane, executive director and vice president of the Allen Institute for Cell Science. (Allen Institute Photo) The Allen Institute was founded more than 20 years ago by the late Microsoft co-founder Paul Allen and his sister Jody Allen to dive into challenging problems in the biosciences. Previous efforts at multiple institutions have created numerical systems for understanding biological processes. That includes BayesSpace, a computational tool that produces data on gene expression in mixed cell types that developed researchers at the Fred Hutch Cancer Center. The Allen Institute has engineered modeling for organelles, which are the various machines packed inside cells that make proteins, produce energy and perform other key operations. 'The exciting thing is that we are trying … to bring different disciplines together,' Gunawardane said, 'because data is everywhere — but how do you make sense out of that data?' The CellScapes researchers are working with human stem cells, which are cells that don't yet have a set identity as, say, a skin or liver cell. The hope is through analysis and experimentation they'll devise mathematics that describe the cell's behavior, ultimately allowing them to predict and manipulate what the cells do. A primary goal would be to use these tools to unravel mysteries such as the intermediate steps to developing cancer, and ultimately discover new cell therapies. 'It's a lot like astronomy and going from 'which planet is that dot in the sky' to 'what are the laws of motion that describe all moving objects?'' said Wallace Marshall, professor of biochemistry and biophysics at the University of California, San Francisco, and a CellScapes advisor, in a statement. The Allen Institute seen from Dexter Yard. (GeekWire File Photo / Charlotte Schubert) The Allen Institute will make its data and innovations in the space publicly available, Gunawardane said, and expects to collaborate with researchers at outside institutions. The research team includes software engineers, computational biologists, program managers and others. There is no set budget for the decade-long effort, and the CellScapes team is simultaneously pursuing three projects that are part of the broader initiative. The effort already has a scientific paper accepted by the journal Nature that will be published in coming months. It's an exciting time, Gunawardane said. 'I also feel a huge responsibility,' she said, 'because Paul [Allen] is not alive anymore, but our work is his legacy, and he asked us to break the code of the cell. And in a way, the code is very complicated — it's more like a program, the cellular program. 'So I feel like we are now actually at the brink,' she said, 'of knowing maybe how to approach that.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store